Tolerance to vancomycin in a multiresistant, Colombian isolate of Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 2, 2003, Pages 300-302

  Hidalgo, Marilyn ^a   Castañeda, Elizabeth ^a   Arias, César A ^b  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b UNIVERSIDAD EL BOSQUE   (Colombia)

Author keywords

Antimicrobial tolerance; Colombian isolates; Killing curves; Streptococcus pneumoniae; Vancomycin

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; CASE REPORT; CELL VIABILITY; CLONAL VARIATION; COLOMBIA; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EXPOSURE; DRUG TOLERANCE; HUMAN; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PEDIATRICS; PENICILLIN RESISTANCE; PRESCHOOL CHILD; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

COLOMBIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG TOLERANCE; HUMANS; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN;

EID: 0043029859     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg336     Document Type: Article

References (10)

1. Schrag, S., Beall, B. & Dowell, S. (2000). Limiting the spread of resistant pneumococci: biological and epidemiological evidence for the effectiveness of alternative interventions. Clinical Microbiology Reviews 13, 588-601.
2. Antón, N., Blásquez, R., Gómez-Garcés, J. L. et al. (2001). Study of vancomycin tolerance in 120 strains of Streptococcus pneumoniae isolated in 1999 in Madrid, Spain. Journal of Antimicrobial Chemotherapy 47, 902-3.
3. Agudelo, C. I., Sanabria, O. M., Ovalle, M. V. et al. (2001). Vigilancia por el laboratorio de Streptococcus pneumoniae, aislado de procesos invasores en niños menores de 5 años. Actualización de los datos 1994-2000. Informe Quincenal Epidemiológico Nacional 7, 97-112.
4. Henriques, B., Novak, R., Örtqvist, A. et al. (2001). Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clinical Infectious Diseases 32, 552-8.
5. Vela, M. C., Fonseca, N., Di Fabio, J. L. et al. (2001). Presence of international multiresistant clones of Streptococcus pneumoniae in Colombia. Microbial Drug Resistance 7, 153-64.
6. National Committee for Clinical Laboratory Standards. (2002). Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA.
7. Grinius, L. L., Coleman, W., Desal, B. et al. (2001). Lack of an antibiotic tolerance phenotype in Vncs deletion mutants of Streptococcus pneumoniae. In Programs and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2001. Abstract C-1-1509, p. 96. American Society for Microbiology, Washington, DC, USA.
8. Robertson, G. T., Zhao, J., Desai, B. V. et al. (2002). Vancomycin tolerance induced by erythromycin but not by loss of vncRS, vex3, or pep27 function in Streptococcus pneumoniae. Journal of Bacteriology 184, 6987-7000.
9. Handwerger, S. & Tomasz, A. (1985). Antibiotic tolerance among clinical isolates of bacteria. Reviews of Infectious Diseases 7, 368-82.
10. Novak, R., Henriques, B., Carpentier, E. et al. (1999). Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 399, 590-3.